Amylyx Pharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Amylyx Pharmaceuticals, Inc. has filed 414 SEC EDGAR filings since 17 Nov 2015

SEC filing history

Showing 326-350 of 414 matching filings.

Per page
25
Current page
14
4

FORM 4

Filing date
09 Sep 2022
Reporting date
08 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
31 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DRS File 377-06329

DRS filing

Filing date
24 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Jul 2022
Reporting date
06 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-93265

SC 13G

Filing date
21 Jun 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
10 Jun 2022
Reporting date
09 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
10 Jun 2022
Reporting date
09 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
10 Jun 2022
Reporting date
09 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
10 Jun 2022
Reporting date
09 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 May 2022
Reporting date
05 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 May 2022
Reporting date
05 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 May 2022
Reporting date
06 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
05 May 2022
Reporting date
06 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-41199

DEFA14A

Filing date
29 Apr 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-41199

DEF 14A

Filing date
29 Apr 2022
Reporting date
09 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-41199

10-K

Filing date
31 Mar 2022
Reporting date
31 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .